---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-017868"
form_type: "8-K"
ticker: "SGHT"
cik: "0001531177"
company_name: "Sight Sciences, Inc."
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T21:48:16.128062+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sight Sciences Q1 revenue up 26% to $18.8M, net loss $17.1M; reaffirms FY2023 guidance

## Summary
- Revenue $18.8M (+26% YoY); Surgical Glaucoma $17.3M (+25%), Dry Eye $1.5M (+47%).
- Net loss $17.1M ($0.35/share) vs $23.3M ($0.49) prior year; operating expenses decreased 2% to $33.3M.
- Gross margin improved to 84% from 80% due to prior year voluntary TearCare SmartHub replacement.
- Reaffirmed FY2023 revenue guidance $89-94M (25-32% growth) and ~$30.5M quarterly adjusted opex.
- Completed commercial launch of Ergo-Series OMNI Surgical System; cash $167.3M, debt $35.0M.

## SEC filing metadata
- accession: 0000950170-23-017868
- form_type: 8-K
- ticker: SGHT
- cik: 0001531177
- company_name: Sight Sciences, Inc.
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1531177/000095017023017868/0000950170-23-017868-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1531177/000095017023017868/sght-20230504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-017868
- JSON: https://secwatch.observer/filing/0000950170-23-017868.json
- Plain text: https://secwatch.observer/filing/0000950170-23-017868.txt

## Key facts
- Earnings Releases
  Sight Sciences, Inc. reported the first quarter ended March 31, 2023 results: revenue $18.8 million, net income $17.1 million, EPS ($0.35) per share. Guidance reaffirmed.
  - Period: the first quarter ended March 31, 2023
  - Revenue: $18.8 million
  - Net income: $17.1 million
  - EPS: ($0.35) per share
  - Guidance: reaffirmed
  - Result: reported results
  source text: results for the first quarter ended March 31, 2023 and reaffirmed guidance for full year 2023. Recent Business and Financial Highlights • Generated first quarter revenue of $18.8 million, an increase of 26% compared to the prior year period • Achieved gross margin of 84% in the first quarter of 2023 versus 80% in the first quarter of 2022 • Completed the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531177/000095017023017868/0000950170-23-017868-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.